Log in to your Inderes Free account to see all free content on this page.
Initiator Pharma
2.99 SEK
+2.75 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Initiator Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -22.3 | |||||||
| EBIT | -4.9 | -4.1 | -22.3 | -4.0 | -5.7 | -6.4 | -10.1 | -25.7 |
| EBIT-% | ||||||||
| Profit before taxes | -4.8 | -4.2 | -22.8 | -4.0 | -5.7 | -6.3 | -8.6 | -24.1 |
| Net income | -4.8 | -1.3 | -19.9 | -4.0 | -5.7 | -6.3 | -4.2 | -19.8 |
Login required
This content is only available for logged in users